BioCryst Pharmaceuticals Inc

11 sept. 2026, 20:08 UTC

BioCryst Pharmaceuticals Inc is lower today, continuing a seven-session decline amid macroeconomic data showing inflation rates in line with expectations.

10 sept. 2026, 23:26 UTC

No specific news was identified for BioCryst Pharmaceuticals Inc. in after-market trading. Shares remained effectively flat since Thursday's close.

9 sept. 2026, 23:46 UTC

BioCryst Pharmaceuticals Inc. shares are higher in after-market trading, despite a generally flat performance and remaining below their 20-day moving average.

8 sept. 2026, 23:16 UTC

BioCryst Pharmaceuticals shares are higher in after-market hours, despite four consecutive lower closes. No specific news was identified to explain the price movement.

3 sept. 2026, 20:07 UTC

BioCryst Pharmaceuticals Inc shares are lower today, continuing a decline since Wednesday. No specific news has been identified to explain the movement.

2 sept. 2026, 23:46 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market hours. No specific news was identified to explain the decline amid broader market sentiment shifts.

1 sept. 2026, 22:26 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market hours following a stable performance. No specific news was identified to explain the price movement.

31 aug. 2026, 20:07 UTC

BioCryst Pharmaceuticals Inc shares are lower today amid broader market declines following inflation concerns from the Jackson Hole Economic Symposium.

28 aug. 2026, 19:16 UTC

BioCryst Pharmaceuticals shares are lower despite reporting Q2 2026 revenue of $218.3 million, reflecting broader market trends and valuation discounts.

27 aug. 2026, 20:07 UTC

BioCryst Pharmaceuticals shares are higher as positive jobless claims data boosts market sentiment. The stock stabilized after reaching a session high.

26 aug. 2026, 19:36 UTC

BioCryst Pharmaceuticals received marketing approval for ORLADEYO in pediatric patients. Shares are lower today amid broader market trends and inflation data.

24 aug. 2026, 19:26 UTC

BioCryst Pharmaceuticals Inc shares are trading higher, maintaining a position above the 20-day moving average and near the midpoint of their one-month range.

21 aug. 2026, 22:26 UTC

BioCryst Pharmaceuticals shares moved higher in after-hours trading, reaching a session high before slightly retracing. No specific news was identified to explain the movement.

20 aug. 2026, 20:01 UTC

BioCryst Pharmaceuticals Inc shares are lower amid a decline in the Biotechnology sub-sector. Earlier in the session, shares rebounded from a session high.

19 aug. 2026, 23:01 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market trading, retracing from an earlier uptick with no specific news identified to explain the decline.

18 aug. 2026, 20:06 UTC

BioCryst Pharmaceuticals Inc shares are declining amid broader market weakness, with no specific news identified to explain today's price movement.

14 aug. 2026, 19:06 UTC

BioCryst Pharmaceuticals is lower today, following broader market concerns over an unexpected drop in U.S. retail sales impacting Federal Reserve interest rate policy.

13 aug. 2026, 21:31 UTC

BioCryst Pharmaceuticals shares traded roughly flat in after-market hours, remaining within their one-month range and above the 20-day moving average.

12 aug. 2026, 19:41 UTC

BioCryst Pharmaceuticals shares are higher today, rebounding from an earlier dip and reflecting notable volatility during the session. The stock remains above its 20-day moving average.

11 aug. 2026, 23:26 UTC

BioCryst Pharmaceuticals Inc shares are lower in after-market hours, reflecting a decline since Tuesday's close amid broader market weakness and cautious sentiment.

10 aug. 2026, 19:51 UTC

BioCryst Pharmaceuticals Inc. shares are higher after Wall Street Zen upgraded its rating to "strong-buy." Other firms also adjusted price targets amid market uncertainty.

7 aug. 2026, 19:56 UTC

BioCryst Pharmaceuticals is trading higher, continuing a positive trend amid easing concerns over interest rate hikes following a disappointing jobs report.

6 aug. 2026, 22:36 UTC

BioCryst Pharmaceuticals shares are lower in after-market trading, continuing a decline since Thursday's close and positioned below the 20-day moving average.

5 aug. 2026, 22:36 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market trading, despite no specific news identified to explain the movement. They remain below their 20-day moving average.

4 aug. 2026, 19:36 UTC

BioCryst Pharmaceuticals Inc shares are higher today, supported by gains in the biotechnology sector. The stock remains above its earlier low despite recent trends.

3 aug. 2026, 19:56 UTC

BioCryst Pharmaceuticals Inc shares are lower today, continuing a downward trend since Friday. The broader market is seeing gains, contrasting with BioCryst's performance.

31 iul. 2026, 22:36 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market trading. No specific news was identified to explain this movement, reflecting routine performance since Friday's close.

30 iul. 2026, 20:09 UTC

BioCryst Pharmaceuticals shares are lower amid broader market volatility following mixed economic signals, including rising jobless claims and disappointing GDP growth.

29 iul. 2026, 19:35 UTC

BioCryst Pharmaceuticals Inc shares are lower amid a declining market, with no specific company news identified to explain the movement during today's session.

28 iul. 2026, 23:06 UTC

BioCryst Pharmaceuticals Inc shares are higher in after-market trading, continuing an upward trend from Tuesday's close, despite an earlier session pullback.